-transparent.png){kind=logo}
Nine patients who had recurrent ventricular fibrillation following acute myocardial infarction or angina were given bretylium tosylate in a dose of 5 mg./kg. intramuscularly every eight hours after other measures had proved ineffective. Provided the patients were not in shock or in heart failure, there was a considerable reduction in the episodes of ventricular fibrillation.A second group of nine patients who developed recurrent ventricular fibrillation following open heart surgery were given bretylium intravenously, which controlled the arrhythmia in every instance.Bretylium did not completely abolish ventricular premature beats but the latter did not initiate ventricular fibrillation even when they occurred on the T wave.
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
April 1984,
Annals of emergency medicine,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
July 1983,
The American journal of emergency medicine,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
June 1980,
Annals of emergency medicine,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
February 1978,
La Clinica terapeutica,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
October 1986,
Annals of internal medicine,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
May 1972,
Circulation,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
December 1984,
Clinical pediatrics,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
April 1966,
The American journal of cardiology,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
July 1969,
Archives of internal medicine,
R W Dhurandhar, and
S J Teasdale, and
W A Mahon
February 1971,
The American journal of cardiology,
